《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读

2019-09-30 中国介入心脏病学杂志.2019,27(9):491-493.

急性肺栓塞（pulmonary embolism，PE）是全球第三大常见的心血管病死因，仅次于冠心病和卒中，其年发病率为（39~115）人/10万人。随着近年来PE领域积累的大量新的循证医学证据，2019年8月31日欧洲心脏病学会（European Society of Cardiology，ESC）携手欧洲呼吸学会（European Respiratory Society，ERS）共同制定的《2

中文标题：

发布机构：

发布日期：

2019-09-30

简要介绍：

急性肺栓塞（pulmonary embolism，PE）是全球第三大常见的心血管病死因，仅次于冠心病和卒中，其年发病率为（39~115）人/10万人。随着近年来PE领域积累的大量新的循证医学证据，2019年8月31日欧洲心脏病学会（European Society of Cardiology，ESC）携手欧洲呼吸学会（European Respiratory Society，ERS）共同制定的《2019年欧洲心脏病学会急性PE诊断和管理指南》。

作者：东南大学附属中大医院心内科汤成春马根山

拓展指南：与肺栓塞相关指南：

有关肺栓塞更多指南

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=60b8d1c00180e1c9, title=《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读, enTitle=, guiderFrom=中国介入心脏病学杂志.2019,27(9):491-493., authorId=null, author=, summary=急性肺栓塞（pulmonary embolism，PE）是全球第三大常见的心血管病死因，仅次于冠心病和卒中，其年发病率为（39~115）人/10万人。随着近年来PE领域积累的大量新的循证医学证据，2019年8月31日欧洲心脏病学会（European Society of Cardiology，ESC）携手欧洲呼吸学会（European Respiratory Society，ERS）共同制定的《2, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Sep 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=急性肺栓塞（pulmonary embolism，PE）是全球第三大常见的心血管病死因，仅次于冠心病和卒中，其年发病率为（39~115）人/10万人。随着近年来PE领域积累的大量新的循证医学证据，2019年8月31日欧洲心脏病学会（European Society of Cardiology，ESC）携手欧洲呼吸学会（European Respiratory Society，ERS）共同制定的《2019年欧洲心脏病学会急性PE诊断和管理指南》。 作者：东南大学附属中大医院心内科汤成春马根山 拓展指南：与肺栓塞相关指南： <ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=e14c31c001603eb5" title="2018 BTS指南：肺栓塞早期门诊管理" target=_blank>2018 BTS指南：肺栓塞早期门诊管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=27a281c00151e10f" title="妇科手术后深静脉血栓形成及肺栓塞预防专家共识" target=_blank>妇科手术后深静脉血栓形成及肺栓塞预防专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0285f1c001353605" title="急性肺栓塞的危险分层及诊断策略—解读《2008ESC急性肺栓塞诊断治疗指南》" target=_blank>急性肺栓塞的危险分层及诊断策略—解读《2008ESC急性肺栓塞诊断治疗指南》</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c30491c0013a0ea4" title="2015 NICE技术评估指南：阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防（TA341）" target=_blank>2015 NICE技术评估指南：阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防（TA341）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=941941c001266100" title="2015 急性肺栓塞诊断与治疗中国专家共识" target=_blank>2015 急性肺栓塞诊断与治疗中国专家共识</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%BA%E6%A0%93%E5%A1%9E" target=_blank>有关肺栓塞更多指南</a></ul>, tagList=[TagDto(tagId=17921, tagName=急性肺栓塞)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12647, appHits=1401, showAppHits=20, pcHits=3506, showPcHits=9120, likes=61, shares=70, comments=24, approvalStatus=1, publishedTime=Tue Oct 22 21:45:22 CST 2019, publishedTimeString=2019-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 22 21:45:22 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:12:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读)])

《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读

下载请点击：

评论区 (21)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1085627, encodeId=7a1b108562e8b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:27 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085626, encodeId=92b3108562604, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:16 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066265, encodeId=0bd31066265b2, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:05 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064212, encodeId=c67b10642121b, content=太实用了，好好学习！ , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/52620ed6746240418388427b16413fa0/aaf13045361f44a9af4022af164cfaca.jpg, createdBy=dddf5435645, createdName=ms6000001734915035, createdTime=Tue Oct 26 23:09:41 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062545, encodeId=d08d106254539, content=太实用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3971544629, createdName=dmq623, createdTime=Thu Oct 21 11:31:24 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
2021-12-30 ms2000001285500485

很好

49 0
[GetPortalCommentsPageByObjectIdResponse(id=1085627, encodeId=7a1b108562e8b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:27 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085626, encodeId=92b3108562604, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:16 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066265, encodeId=0bd31066265b2, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:05 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064212, encodeId=c67b10642121b, content=太实用了，好好学习！ , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/52620ed6746240418388427b16413fa0/aaf13045361f44a9af4022af164cfaca.jpg, createdBy=dddf5435645, createdName=ms6000001734915035, createdTime=Tue Oct 26 23:09:41 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062545, encodeId=d08d106254539, content=太实用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3971544629, createdName=dmq623, createdTime=Thu Oct 21 11:31:24 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
2021-12-30 ms2000001285500485

很棒

64 0
[GetPortalCommentsPageByObjectIdResponse(id=1085627, encodeId=7a1b108562e8b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:27 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085626, encodeId=92b3108562604, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:16 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066265, encodeId=0bd31066265b2, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:05 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064212, encodeId=c67b10642121b, content=太实用了，好好学习！ , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/52620ed6746240418388427b16413fa0/aaf13045361f44a9af4022af164cfaca.jpg, createdBy=dddf5435645, createdName=ms6000001734915035, createdTime=Tue Oct 26 23:09:41 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062545, encodeId=d08d106254539, content=太实用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3971544629, createdName=dmq623, createdTime=Thu Oct 21 11:31:24 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
2021-11-02 taken110

好资源，想学习

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1085627, encodeId=7a1b108562e8b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:27 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085626, encodeId=92b3108562604, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:16 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066265, encodeId=0bd31066265b2, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:05 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064212, encodeId=c67b10642121b, content=太实用了，好好学习！ , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/52620ed6746240418388427b16413fa0/aaf13045361f44a9af4022af164cfaca.jpg, createdBy=dddf5435645, createdName=ms6000001734915035, createdTime=Tue Oct 26 23:09:41 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062545, encodeId=d08d106254539, content=太实用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3971544629, createdName=dmq623, createdTime=Thu Oct 21 11:31:24 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
2021-10-26 ms6000001734915035

太实用了，好好学习！

68 0
[GetPortalCommentsPageByObjectIdResponse(id=1085627, encodeId=7a1b108562e8b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:27 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085626, encodeId=92b3108562604, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Thu Dec 30 00:59:16 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066265, encodeId=0bd31066265b2, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:05 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064212, encodeId=c67b10642121b, content=太实用了，好好学习！ , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/52620ed6746240418388427b16413fa0/aaf13045361f44a9af4022af164cfaca.jpg, createdBy=dddf5435645, createdName=ms6000001734915035, createdTime=Tue Oct 26 23:09:41 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062545, encodeId=d08d106254539, content=太实用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3971544629, createdName=dmq623, createdTime=Thu Oct 21 11:31:24 CST 2021, time=2021-10-21, status=1, ipAttribution=)]
2021-10-21 dmq623

太实用了

70 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读

相关指南

科室

工具

服务